Wolters Kluwer Chief Medical Officer Explores GenAI & Burnout at HIMSS AI in Healthcare Forum

August 29, 2024 11:38 PM AEST | By EODHD
 Wolters Kluwer Chief Medical Officer Explores GenAI & Burnout at HIMSS AI in Healthcare Forum
Image source: Kalkine Media
CMO Dr. Peter Bonis will examine the issue of trust in workforce AI adoption WALTHAM, Mass., August 29, 2024--(BUSINESS WIRE)--Dr. Peter Bonis, Chief Medical Officer for Wolters Kluwer Health, will speak on artificial intelligence (AI) at the HIMSS AI in Healthcare Forum. The panel, titled "How Do We Support our Workforce to Trust and Adopt AI?" will be held on Thursday, September 5 from 1:15-2:05 PM in Boston. "Successful adoption of AI in the healthcare setting requires demonstration of value, safety, and effectiveness," said Dr.

Bonis. "Trust must be earned. For example, an April 2024 Wolters Kluwer survey found nine out of 10 physicians have concerns about the source of GenAI content used for clinical decision support and they want transparency. I look forward to discussing the progress and barriers on adoption of AI technologies in the clinical setting." Joining Dr. Bonis on the panel are Dr.

Patrick Thomas, Director of Digital Innovation, Pediatric Surgery, The University of Nebraska Medical Center-College of Medicine; Dr. Sonya Makhni, Medical Director, Mayo Clinic Platform; and Dr. Antoine Keller, Cardiothoracic Surgeon at Ochsner Lafayette General Hospital. The panel will address the importance of ensuring a healthcare organization’s workforce is prepared and willing to effectively leverage AI in their clinical workflows. During the panel, AI clinician-experts will dive into the skills needed to build readiness for successful workforce adoption and trust in AI.

Building on Wolters Kluwer’s solid AI foundation Wolters Kluwer Health is already working with healthcare systems to explore integrating GenAI into UpToDate through its experimental AI Labs. The company is committed to setting a standard for the responsible application of generative AI to the complex realities of front-line healthcare. A recent Wolters Kluwer Health survey, "Generative AI in Healthcare: Growing Physician Enthusiasm," found 4 out of 5 of physicians (81%) say GenAI can improve care team interactions with patients. Wolters Kluwer AI products, services, and expert solutions are based on a foundation of trust, transparency, and responsibility—in line with the company’s values. Wolters Kluwer’s AI Principles, which guide the design, development and deployment of advanced technologies in helping customers solve their most complex problems, can be found here.

About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Story continues Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram. View source version on businesswire.com: https://www.businesswire.com/news/home/20240829282224/en/ Contacts Media Suzanne Moran Associate Director, External Communications Wolters Kluwer Health +1 (781) 255-5843 [email protected] View comments

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.